EBO-301 Treatment-refractory Mycobacterium avium complex (MAC) lung disease
Principal Investigator: Amee Patrawalla
Affiliation: Associate Professor and Program Director of Pulmonary and Critical Care at Rutgers New Jersey Medical School
Amount: $160,016.00
Sponsor: AN2 Therapeutics, Inc.